Taxonera, C., Fernández‐Aceñero, M. J., Olivares, D., Calvo, M., Casis, B., Bermejo, F., . . . Alba, C. (2022). Association of golimumab trough concentrations during maintenance with clinical, biological, endoscopic and histologic remission in patients with ulcerative colitis. Alimentary Pharmacology & Therapeutics, 56(4), 614. https://doi.org/10.1111/apt.16964
Chicago Style (17th ed.) CitationTaxonera, Carlos, et al. "Association of Golimumab Trough Concentrations During Maintenance with Clinical, Biological, Endoscopic and Histologic Remission in Patients with Ulcerative Colitis." Alimentary Pharmacology & Therapeutics 56, no. 4 (2022): 614. https://doi.org/10.1111/apt.16964.
MLA (9th ed.) CitationTaxonera, Carlos, et al. "Association of Golimumab Trough Concentrations During Maintenance with Clinical, Biological, Endoscopic and Histologic Remission in Patients with Ulcerative Colitis." Alimentary Pharmacology & Therapeutics, vol. 56, no. 4, 2022, p. 614, https://doi.org/10.1111/apt.16964.